Edition:
United Kingdom

Athersys Inc (ATHX.OQ)

ATHX.OQ on NASDAQ Stock Exchange Capital Market

2.09USD
23 Apr 2018
Change (% chg)

-- (--)
Prev Close
$2.09
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
129,509
52-wk High
$2.62
52-wk Low
$1.29

Chart for

About

Athersys, Inc. is an international biotechnology company that is focused primarily in the field of regenerative medicine. The Company's MultiStem cell therapy, an allogeneic stem cell product, is its lead platform product and is in later-stage clinical development. Its clinical development programs are focused on treating... (more)

Overall

Beta: -0.38
Market Cap(Mil.): $275.67
Shares Outstanding(Mil.): 113.91
Dividend: --
Yield (%): --

Financials

  ATHX.OQ Industry Sector
P/E (TTM): -- 84.02 32.74
EPS (TTM): -0.26 -- --
ROI: -103.95 1.58 14.38
ROE: -109.33 2.41 16.07

BRIEF-Uthealth In Houston And Athersys Announce Funding For Clinical Trial Using Multistem® To Treat Trauma Patients

* UTHEALTH IN HOUSTON AND ATHERSYS ANNOUNCE FUNDING FOR CLINICAL TRIAL USING MULTISTEM® TO TREAT TRAUMA PATIENTS Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

23 Apr 2018

BRIEF-Healios K.K. Reports 8.7 Pct Stake In Athersys

* HEALIOS K.K. REPORTS 8.7 PERCENT STAKE IN ATHERSYS INC AS OF MARCH 13, 2018 - SEC FILING‍​ Source text: (https://bit.ly/2G0glmi)

23 Mar 2018

BRIEF-Athersys Reports Q4 Revenue $1.2 Million Versus $1.0 Million

* ATHERSYS REPORTS FINANCIAL RESULTS FOR FOURTH QUARTER, FULL YEAR 2017

13 Mar 2018

BRIEF-Athersys Inc Files Prospectus Relates Potential Sale Of Up To 24.7 mln Shares Of Co's Common Stock By Aspire Capital

* ATHERSYS INC FILES PROSPECTUS RELATES POTENTIAL SALE OF UP TO 24.7 MILLION SHARES OF CO'S COMMON STOCK BY ASPIRE CAPITAL - SEC FILING‍​ Source text - (http://bit.ly/2nyf89E) Further company coverage:

02 Feb 2018

BRIEF-Athersys Enters Into New $100 Mln Equity Facility With Aspire Capital

* ATHERSYS ENTERS INTO NEW $100 MILLION EQUITY FACILITY WITH ASPIRE CAPITAL

02 Feb 2018

BRIEF-Athersys Says On Feb 1, Co Entered Into Common Stock Purchase Agreement With Aspire Capital Fund

* ATHERSYS INC SAYS ON FEB 1, CO ENTERED INTO COMMON STOCK PURCHASE AGREEMENT WITH ASPIRE CAPITAL FUND - SEC FILING

01 Feb 2018

BRIEF-Athersys reports Q3 loss per share $0.06

* Q3 earnings per share view $-0.06 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

08 Nov 2017

Earnings vs. Estimates